Cardinal Health Inc (CAH) : Cwm scooped up 205,904 additional shares in Cardinal Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 17, 2016. The investment management firm now holds a total of 206,114 shares of Cardinal Health Inc which is valued at $15,514,201.Cardinal Health Inc makes up approximately 1.11% of Cwm’s portfolio.
Other Hedge Funds, Including , British Columbia Investment Management Corp reduced its stake in CAH by selling 22,443 shares or 13.55% in the most recent quarter. The Hedge Fund company now holds 143,181 shares of CAH which is valued at $10,784,393. Cardinal Health Inc makes up approx 0.11% of British Columbia Investment Management Corp’s portfolio. Pensionfund Dsm Netherlands sold out all of its stake in CAH during the most recent quarter. The investment firm sold 48,000 shares of CAH which is valued $3,615,360.
Cardinal Health Inc closed down -0.07 points or -0.09% at $75.27 with 14,69,061 shares getting traded on Friday. Post opening the session at $75.66, the shares hit an intraday low of $75.07 and an intraday high of $75.85 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.
Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Downgraded by Goldman to ” Neutral” on Sep 16, 2016.
Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.